Indaptus Therapeutics Reports Critical Cash Shortage, Less Than One Month of Operating Funds Remaining

summarizeSummary

Indaptus Therapeutics disclosed a critically low cash balance of $1.5 million, with a burn rate of $7.0 million per quarter, indicating less than one month of operating funds remaining and an urgent need for new capital.

check_boxKey Events

• Critically Low Cash Position

  Cash and cash equivalents plummeted to $1.5 million as of March 31, 2026, down from $8.5 million at the end of 2025.

• Rapid Cash Burn

  The company used $7.0 million in cash from operating activities during Q1 2026, implying a burn rate that far exceeds its current cash reserves.

• Urgent Need for Capital

  Management explicitly stated the company needs to raise additional capital to continue operations, with no assurance that financing will be available on acceptable terms or at all.

• Reiteration of Going Concern

  The filing reinforces the substantial doubt about the company's ability to continue as a going concern, a warning previously issued in its 10-K.

auto_awesomeAnalysis

Indaptus Therapeutics has reported a critically low cash balance of $1.5 million as of March 31, 2026, while burning $7.0 million in cash from operations during the first quarter. This indicates the company has less than one month of operating funds remaining, exacerbating the previously disclosed going concern warning. The company explicitly states it needs to raise additional capital but cannot assure its availability, putting its future operations in severe jeopardy.